Renalytix plc
RNLXY· OTC
RNLXYRenalytix plc
Filed May 15, 2024 · 10-Q · 45 days after period end · 0000950170-24-060033
| Metric | Q3 2024 | Q3 2023 |
|---|---|---|
| Revenue | $535.00K | $724.00K |
| Net Income | -$7.74M | -$12.11M |
| EPS Diluted | -$0.08 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Renalytix plc · CIK 1811115 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end
